MaxCyte Bolsters Leadership Team with Promotion of Brad Calvin to Chief Commercial Officer and New Key VP Appointments

GAITHERSBURG, Md., Oct. 13, 2020 /PRNewswire/ — MaxCyte, Inc., a global cell-based therapies and life sciences company, announces today a senior leadership promotion and appointments for two key vice president roles.

Brad Calvin has been promoted to Chief Commercial Officer. In his previous role as MaxCyte Executive Vice President, Global Commercial Operations, Mr. Calvin was responsible for leading the Company’s sales, marketing and business development functions to define product strategy, deliver new products and drive growth of its drug discovery and cell therapy businesses.  In addition, Sarah Haecker Meeks, PhD, has joined the Company as Vice President, Business Development, and Steve Nardi has joined as Vice President, Manufacturing and Engineering Operations. 

MaxCyte’s President & CEO Doug Doerfler, said: “Brad’s promotion is well-earned and important for MaxCyte’s future growth. Since joining MaxCyte in 2017, he has forged pivotal relationships with leading cell therapy and gene editing companies, leading

Read More
Read More

DXC Technology Announces Leadership Appointments to Support the “new DXC”

The MarketWatch News Department was not involved in the creation of this content.

DXC Technology (NYSE:DXC) today presented its latest leadership appointments further strengthening the DXC leadership team, the majority being new to DXC within the last year. This team is bringing the “new DXC,” which is focused on its customers and its people, to the market as it executes the company’s transformation journey.

DXC Customer Portfolio Leadership

Over the past year, CEO Mike Salvino has recruited new IT services industry leaders who bring formidable experience delivering for customers, inspiring people, and running and growing businesses. DXC announces the following appointments and changes to the team that will run DXC’s business and lead execution of the DXC transformation journey:

  • Americas will be led byJim Brady and David Swift. Jim joined DXC in June 2020 from Accumen, where he was the COO and previously worked at Accenture and Honeywell.
Read More
Read More

DXC Technology Announces Leadership Appointments to Support the “new DXC”

DXC Technology (NYSE:DXC) today presented its latest leadership appointments further strengthening the DXC leadership team, the majority being new to DXC within the last year. This team is bringing the “new DXC,” which is focused on its customers and its people, to the market as it executes the company’s transformation journey.

DXC Customer Portfolio Leadership

Over the past year, CEO Mike Salvino has recruited new IT services industry leaders who bring formidable experience delivering for customers, inspiring people, and running and growing businesses. DXC announces the following appointments and changes to the team that will run DXC’s business and lead execution of the DXC transformation journey:

  • Americas will be led by Jim Brady and David Swift. Jim joined DXC in June 2020 from Accumen, where he was the COO and previously worked at Accenture and Honeywell. David Swift joined DXC in November 2019 from Accolade where he was Chief

Read More
Read More